Sucampo Pharmaceuticals, Inc. Stock

Stocks

17-12-26	Wall Street slips on tech sector weakness	RE
17-12-26	Mallinckrodt : to buy Sucampo for about $840 million	RE
16-11-09	Boeing : U.S. companies react cautiously to Trump victory	RE

18-01-25	Monteverde & Associates PC : Files Class Action Lawsuit On Behalf Of Shareholders Of Sucampo Pharmaceuticals, Inc. In The District Of Maryland	PR
18-01-22	SUCAMPO PHARMACEUTICALS : SCMP) Andrews & Springer LLC Is Investigating Sucampo Pharmaceuticals, Inc. for Potential Breaches of Fiduciary Duty	BU
18-01-03	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Sucampo Pharmaceuticals, Inc. to Mallinckrodt plc is Fair to Shareholders	BU
18-01-01	Monteverde & Associates PC Announces An Investigation Of Sucampo Pharmaceuticals, Inc. -- SCMP	PR
17-12-29	SUCAMPO PHARMACEUTICALS, INC. Former SEC Attorney Willie Briscoe Investigates Sale to Mallinckrodt plc	BU

17-12-26	Apple : POINT Marchés-Wall Street finit peu changée, freinée par Apple
17-12-26	Apple : Les valeurs à suivre à Wall Street
17-12-08	Alexion Pharmaceuticals : Les valeurs à suivre à Wall Street
17-12-07	Sucampo Pharmaceuticals : La biotech américaine Sucampo envisage de se vendre
17-04-19	Sucampo Pharmaceuticals : Veröffentlichung einer neuen Studie zu VTS-270 für die Behandlung von Morbus Niemann-Pick Typ C1 im Online-Fachjournal PLOS ONE Advances Science

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SUCAMPO PHARMACEUTICALS, INC.	-.--%	-.--%	-	-	0
WUXI APPTEC CO., LTD.	+2.35%	+2.74%	+33.41%	+79.20%	56.54B
ARGENX SE	-0.21%	-7.38%	+25.34%	+63.02%	53.6B
BIONTECH SE	-2.44%	+1.40%	-15.74%	-16.80%	22.91B
INSMED INCORPORATED	-2.85%	-7.78%	-8.09%	+346.36%	21.37B
WUXI BIOLOGICS (CAYMAN) INC.	+2.49%	-0.92%	+20.31%	-12.15%	20.27B
GENMAB A/S	+0.79%	-1.06%	+29.29%	-33.32%	17.56B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+0.58%	-5.88%	+16.30%	+540.37%	14.75B
EXELIXIS, INC.	-5.25%	-4.23%	+46.41%	+169.05%	13.33B
PHARMAESSENTIA CORPORATION	+3.41%	-6.61%	+163.08%	+280.43%	13.53B
Average	-0.11%	-3.79%	+34.48%	+157.35%	25.98B
Weighted average by Cap.	+0.23%	-2.96%	+28.67%	+119.98%